Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2015 2
2016 1
2017 1
2020 1
2021 2
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

8 results
Results by year
Filters applied: . Clear all
Page 1
Showing results for austria on[au]
Your search for Austriaco ON[au] retrieved no results
Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack.
Gur C, Ibrahim Y, Isaacson B, Yamin R, Abed J, Gamliel M, Enk J, Bar-On Y, Stanietsky-Kaynan N, Coppenhagen-Glazer S, Shussman N, Almogy G, Cuapio A, Hofer E, Mevorach D, Tabib A, Ortenberg R, Markel G, Miklić K, Jonjic S, Brennan CA, Garrett WS, Bachrach G, Mandelboim O. Gur C, et al. Among authors: bar on y. Immunity. 2015 Feb 17;42(2):344-355. doi: 10.1016/j.immuni.2015.01.010. Epub 2015 Feb 10. Immunity. 2015. PMID: 25680274 Free PMC article.
Amelanotic B16-F10 Melanoma Compatible with Advanced Three-Dimensional Imaging Modalities.
Tikoo S, Jain R, Tomasetig F, On K, Martinez B, Heu C, Stehle D, Obeidy P, Guo D, Vincent JN, Cook AJL, Roediger B, Feil R, Whan RM, Weninger W. Tikoo S, et al. Among authors: on k. J Invest Dermatol. 2021 Aug;141(8):2090-2094.e6. doi: 10.1016/j.jid.2021.01.025. Epub 2021 Mar 4. J Invest Dermatol. 2021. PMID: 33675788 No abstract available.
Octenidine: Novel insights into the detailed killing mechanism of Gram-negative bacteria at a cellular and molecular level.
Malanovic N, Ön A, Pabst G, Zellner A, Lohner K. Malanovic N, et al. Among authors: on a. Int J Antimicrob Agents. 2020 Nov;56(5):106146. doi: 10.1016/j.ijantimicag.2020.106146. Epub 2020 Aug 25. Int J Antimicrob Agents. 2020. PMID: 32853670 Free article.
The objective of our study was to investigate the mode of action of OCT's potent effect on Gram-negative bacteria using Escherichia coli as a model organism as well as corresponding model membranes. ...
The objective of our study was to investigate the mode of action of OCT's potent effect on Gram-negative bacteria using Escherichia c …
European consensus on the concepts and measurement of the pathophysiological neuromuscular responses to passive muscle stretch.
van den Noort JC, Bar-On L, Aertbeliën E, Bonikowski M, Braendvik SM, Broström EW, Buizer AI, Burridge JH, van Campenhout A, Dan B, Fleuren JF, Grunt S, Heinen F, Horemans HL, Jansen C, Kranzl A, Krautwurst BK, van der Krogt M, Lerma Lara S, Lidbeck CM, Lin JP, Martinez I, Meskers C, Metaxiotis D, Molenaers G, Patikas DA, Rémy-Néris O, Roeleveld K, Shortland AP, Sikkens J, Sloot L, Vermeulen RJ, Wimmer C, Schröder AS, Schless S, Becher JG, Desloovere K, Harlaar J. van den Noort JC, et al. Among authors: bar on l. Eur J Neurol. 2017 Jul;24(7):981-e38. doi: 10.1111/ene.13322. Epub 2017 May 29. Eur J Neurol. 2017. PMID: 28557247
Disruption of the Cytoplasmic Membrane Structure and Barrier Function Underlies the Potent Antiseptic Activity of Octenidine in Gram-Positive Bacteria.
Malanovic N, Buttress JA, Vejzovic D, Ön A, Piller P, Kolb D, Lohner K, Strahl H. Malanovic N, et al. Among authors: on a. Appl Environ Microbiol. 2022 May 24;88(10):e0018022. doi: 10.1128/aem.00180-22. Epub 2022 Apr 28. Appl Environ Microbiol. 2022. PMID: 35481757 Free PMC article.
To eliminate a wide spectrum of disease-causing microorganisms, a compound's antiseptic activity should be unspecific or multitarget. Our results demonstrate an unspecific mechanism of action for OCT, which remained largely unknown for years. ...Because OCT does not distin …
To eliminate a wide spectrum of disease-causing microorganisms, a compound's antiseptic activity should be unspecific or multitarget. …